Active Biotech Future Growth
Future criteria checks 3/6
Active Biotech is forecast to grow earnings and revenue by 119.6% and 150% per annum respectively.
Key information
119.6%
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 19.3% |
| Revenue growth rate | 150.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 09 Feb 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | 146 | 107 | 102 | 102 | 1 |
| 12/31/2023 | N/A | -42 | -50 | -50 | 1 |
| 12/31/2022 | N/A | -58 | -55 | -55 | N/A |
| 9/30/2022 | N/A | -60 | -57 | -57 | N/A |
| 6/30/2022 | N/A | -57 | -55 | -55 | N/A |
| 3/31/2022 | N/A | -54 | -53 | -53 | N/A |
| 12/31/2021 | N/A | -50 | -46 | -46 | N/A |
| 9/30/2021 | 6 | -38 | -35 | -35 | N/A |
| 6/30/2021 | 6 | -35 | -33 | -33 | N/A |
| 3/31/2021 | 6 | -32 | -29 | -29 | N/A |
| 12/31/2020 | 7 | -32 | -32 | -32 | N/A |
| 9/30/2020 | 1 | -39 | -38 | -38 | N/A |
| 6/30/2020 | 2 | -40 | -37 | -37 | N/A |
| 3/31/2020 | 3 | -36 | -40 | -40 | N/A |
| 12/31/2019 | 8 | -34 | -36 | -36 | N/A |
| 9/30/2019 | 12 | -32 | -35 | -35 | N/A |
| 6/30/2019 | 16 | -31 | -37 | -37 | N/A |
| 3/31/2019 | 21 | -35 | -38 | -38 | N/A |
| 12/31/2018 | 20 | -37 | -41 | -41 | N/A |
| 9/30/2018 | 21 | -88 | -41 | -41 | N/A |
| 6/30/2018 | 21 | -88 | -43 | -43 | N/A |
| 3/31/2018 | 20 | -103 | -44 | -44 | N/A |
| 12/31/2017 | 20 | -109 | -46 | -46 | N/A |
| 9/30/2017 | 22 | -63 | -52 | -52 | N/A |
| 6/30/2017 | 21 | -67 | -57 | -57 | N/A |
| 3/31/2017 | 20 | -59 | -61 | -61 | N/A |
| 12/31/2016 | 19 | -60 | -73 | -73 | N/A |
| 9/30/2016 | 17 | -86 | N/A | -86 | N/A |
| 6/30/2016 | 18 | -97 | N/A | -123 | N/A |
| 3/31/2016 | 17 | -152 | N/A | -187 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0GQU is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.2%).
Earnings vs Market: 0GQU is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0GQU is expected to become profitable in the next 3 years.
Revenue vs Market: 0GQU is forecast to have no revenue next year.
High Growth Revenue: 0GQU is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0GQU's Return on Equity is forecast to be high in 3 years time